Neuren Pharmaceuticals | NEU - Credores Comerciais

Preço das Ações
12.61
Mudança Diária
0.15 1.20%
Mensal
4.82%
Anual
1.37%
Q2 Previsão
12.10




Credores Comerciais Alterar Data
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 613K 230K 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Clinuvel Pharmaceuticals AUD 10.68M 731.35K 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Genetic Signatures AUD 3.63M 1.25M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Medical Developments International AUD 4.31M 2.18M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organon & Co USD 952M 122M 2025-12
Paradigm Biopharmaceuticals AUD 4.44M 1.71M 2025-12
PYC Therapeutics AUD 9.56M 802.76K 2025-12
Starpharma Holdings AUD 2.67M 618K 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Telix Pharmaceuticals AUD 71.66M 19.98M 2025-12
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12